Potential place for FERACCRU® in the treatment pathway
Diagram does not represent clinical guidelines for the management of IDA
FERACCRU® should not be used in patients with an inflammatory bowel disease (IBD) flare or in IBD patients with haemoglobin (Hb) <9.5 g/dl1
World Health Organization (WHO) definitions for mild, moderate and severe anaemia can be found here2
Please refer to the prescribing information and GB SPC or NI SPC before prescribing.